Wikipedia
MitraClip is a novel, percutaneous method of treatment that is targeted for patients who have been denied surgery to fix mitral valve regurgitation. MitraClip is the only alternative to mitral valve regurgitation surgery that has been approved by the FDA. Open-heart surgery is the standard method of treatment for patients with mitral valve regurgitation, however it is very invasive and not a feasible option for all patients. The risk of complications and mortality greatly increase in patients with other health conditions like liver disease, previous chest surgeries, and age above 75, which is why they are often denied surgery. The implantation of MitraClip does not involve open-heart surgery, but mimics the surgical method of edge-to-edge valve repair. The mitral valve leaflets are clipped together with the device instead of being sutured together, making this procedure much less invasive but still effective. The MitraClip is made of chromium and cobalt and is covered in polyester to promote the growth of tissue around the clip.
MitraClip is manufactured by Abbott Laboratories.